Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness.

C Desloovere; Rainald Knecht; P Germonpré

Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness.

Standard

Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness. / Desloovere, C; Knecht, Rainald; Germonpré, P.

In: B-ENT, Vol. 2, No. 2, 2, 2006, p. 69-73.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Desloovere, C, Knecht, R & Germonpré, P 2006, 'Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness.', B-ENT, vol. 2, no. 2, 2, pp. 69-73. <http://www.ncbi.nlm.nih.gov/pubmed/16910290?dopt=Citation>

APA

Desloovere, C., Knecht, R., & Germonpré, P. (2006). Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness. B-ENT, 2(2), 69-73. [2]. http://www.ncbi.nlm.nih.gov/pubmed/16910290?dopt=Citation

Vancouver

Desloovere C, Knecht R, Germonpré P. Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness. B-ENT. 2006;2(2):69-73. 2.

Bibtex

@article{9af8595fe7bf413ebb84192154a98d30,

title = "Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness.",

abstract = "PROBLEMS/OBJECTIVES: We investigated the effect of secondary hyperbaric oxygen therapy (HBO) for patients with idiopathic sudden sensorineural hearing loss after unsuccessful conventional treatment. METHODOLOGY: We retrospectively evaluated 3 groups: 100 patients without further treatment (group 1), 160 patients with secondary HBO at 1.5 ATA (group 2), and 56 patients with secondary HBO at 2.5 ATA (group 3). RESULTS: In group 1, a mean hearing gain (MHG) of 2.6 +/- 15 dB was found at the end of the follow-up period. After HBO, a MHG of 3.1 +/- 9 dB in group 2 and 19.7 +/- 23 dB in group 3 was achieved. The results in group 3 were statistically significant in comparison to group 1 (p <0.007) and to group 2 (p <0.009). With HBO after initial therapy failure, there is a significant correlation of MHG with time delay before HBO (p <0.03). CONCLUSIONS: HBO at 2.5 ATA in patients with idiopathic sudden sensorineural hearing loss after unsuccessful conventional treatment yields significant improvement of hearing. MHG is higher when time delay before HBO is shorter.",

author = "C Desloovere and Rainald Knecht and P Germonpr{\'e}",

year = "2006",

language = "Deutsch",

volume = "2",

pages = "69--73",

journal = "B-ENT",

issn = "1781-782X",

publisher = "Koninklijke Belgische Vereniging voor ORL Gelaat en Halschirugie",

number = "2",

}

RIS

TY - JOUR

T1 - Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness.

AU - Desloovere, C

AU - Knecht, Rainald

AU - Germonpré, P

PY - 2006

Y1 - 2006

N2 - PROBLEMS/OBJECTIVES: We investigated the effect of secondary hyperbaric oxygen therapy (HBO) for patients with idiopathic sudden sensorineural hearing loss after unsuccessful conventional treatment. METHODOLOGY: We retrospectively evaluated 3 groups: 100 patients without further treatment (group 1), 160 patients with secondary HBO at 1.5 ATA (group 2), and 56 patients with secondary HBO at 2.5 ATA (group 3). RESULTS: In group 1, a mean hearing gain (MHG) of 2.6 +/- 15 dB was found at the end of the follow-up period. After HBO, a MHG of 3.1 +/- 9 dB in group 2 and 19.7 +/- 23 dB in group 3 was achieved. The results in group 3 were statistically significant in comparison to group 1 (p <0.007) and to group 2 (p <0.009). With HBO after initial therapy failure, there is a significant correlation of MHG with time delay before HBO (p <0.03). CONCLUSIONS: HBO at 2.5 ATA in patients with idiopathic sudden sensorineural hearing loss after unsuccessful conventional treatment yields significant improvement of hearing. MHG is higher when time delay before HBO is shorter.

AB - PROBLEMS/OBJECTIVES: We investigated the effect of secondary hyperbaric oxygen therapy (HBO) for patients with idiopathic sudden sensorineural hearing loss after unsuccessful conventional treatment. METHODOLOGY: We retrospectively evaluated 3 groups: 100 patients without further treatment (group 1), 160 patients with secondary HBO at 1.5 ATA (group 2), and 56 patients with secondary HBO at 2.5 ATA (group 3). RESULTS: In group 1, a mean hearing gain (MHG) of 2.6 +/- 15 dB was found at the end of the follow-up period. After HBO, a MHG of 3.1 +/- 9 dB in group 2 and 19.7 +/- 23 dB in group 3 was achieved. The results in group 3 were statistically significant in comparison to group 1 (p <0.007) and to group 2 (p <0.009). With HBO after initial therapy failure, there is a significant correlation of MHG with time delay before HBO (p <0.03). CONCLUSIONS: HBO at 2.5 ATA in patients with idiopathic sudden sensorineural hearing loss after unsuccessful conventional treatment yields significant improvement of hearing. MHG is higher when time delay before HBO is shorter.

M3 - SCORING: Zeitschriftenaufsatz

VL - 2

SP - 69

EP - 73

JO - B-ENT

JF - B-ENT

SN - 1781-782X

IS - 2

M1 - 2

ER -